Open access
Jul 2026
Dual residual risk of lipid and inflammation: a prospective analysis of RCII on hypertension incidence and cardiovascular prognosis in Chinese and UK populations.
Findings support RCII as a complementary lipid-inflammatory residual-risk marker; however, external validation and decision-utility studies are needed before clinical implementation.
Lerui Wang, Si-Yuan Wen, Zhiyi Ma et al.
· BMC Cardiovascular Disorders · 0 citations